Hot Stocks Alert: Biogen Idec Inc (NASDAQ:BIIB), Synta Pharmaceuticals Corp ... Market News Call As part of the relationship, Biogen Idec will supply UCB with its portfolio of multiple sclerosis (MS) therapies and investigational candidates, including TECFIDERA®, FAMPYRA®, AVONEX®, TYSABRI®, PLEGRIDY™ and Daclizumab High-Yield Process ... |
